About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
News
Recent news about Panacea Capital and select portfolio companies
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
October 30, 2026
Labiotech – ESMO 2026: Readouts and Highlights at the Oncology Summit
October 30, 2026
Labiotech – ESMO 2026: Readouts and Highlights at the Oncology Summit
October 9, 2026
Shaping the Next Era of Global Biomanufacturing: Chime Biologics Brings Its “GMP” Vision to CPHI Milan 2026
October 9, 2026
Shaping the Next Era of Global Biomanufacturing: Chime Biologics Brings Its “GMP” Vision to CPHI Milan 2026
September 23, 2026
Chime Biologics and Magic Mirror Biotech Enter Strategic Partnership to Advance AI-Enabled Intelligent Manufacturing Across the Biologics Lifecycle
September 23, 2026
Chime Biologics and Magic Mirror Biotech Enter Strategic Partnership to Advance AI-Enabled Intelligent Manufacturing Across the Biologics Lifecycle
September 11, 2026
pharmaphorum – How today’s biotechs are helping us Stand up To Cancer
September 11, 2026
pharmaphorum – How today’s biotechs are helping us Stand up To Cancer
1 / 17
Next